CRJZ

同壁财经 · May 30 at 10:32 AM

CRJZ has continuously received a Wind ESG A rating, with a comprehensive score of 7.82

AASTOCKS · Mar 19 at 09:22 AM

China Resources Pharma's subsidiary China Resources Jiangzhong earned 907 million RMB last year, an increase of 15%

AASTOCKS · Jan 25 at 03:47 AM

China Resources Pharma's subsidiary China Resources Jiangzhong earned 906 million RMB last year, an increase of 15%

Zhitong · Oct 24, 2025 at 04:44 AM

China Resources Pharmaceutical: JZYY's net profit for the first three quarters is 743 million yuan, an increase of 6.02% year-on-year

Zhitong · Oct 24, 2025 at 04:26 AM

JZYY: The net profit attributable to the parent company in the third quarter was 161 million yuan, an increase of 4.70% year-on-year

Zhitong · Sep 2, 2025 at 06:41 PM

Zhongtai Securities: The gross profit margin of the Chinese medicine sector is expected to recover in H2 2025, optimistic about leading brands in OTC and innovative pipelines